Industry News
Molecular machine, not assembly line, assembles microtubules
8/21/2015
When they think about how cells put together the molecules that make life work, biologists have tended to think of assembly lines: Add A to B, tack on C, and so on.
People with fewer moles may face risk of more aggressive melanoma
8/21/2015
While people with fewer than 50 moles may not be as at risk for melanoma as people with more moles, they may be more at risk for aggressive melanoma, according to new research.
FDA approves Adcetris for high risk Hodgkin Lymphoma patients
8/20/2015
Seattle Genetics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ADCETRIS (brentuximab vedotin) for the treatment of patients with classical Hodgkin lymphoma (HL)...
FDA approves Adcetris for high risk Hodkin Lymphoma patients
8/20/2015
Seattle Genetics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ADCETRIS (brentuximab vedotin) for the treatment of patients with classical Hodgkin lymphoma (HL)...
Divide and rule: a tumour's strategy
8/20/2015
Researchers supported by the Swiss National Science Foundation have discovered how aggressive cells can invade healthy tissue during the earliest stage of tumour development.
Results of the landmark CATCH (Comparison of Acute Treatments in Cancer Haemostasis) study were published on the 18th August in The Journal of American Medical Association (JAMA), comparing...
How do celebrities influence public health decisions?
8/20/2015
We investigate the ways in which celebrities can influence public health care practices and take a look at the mechanisms that might explain them.
A metabolic master switch underlying human obesity
8/20/2015
Obesity is one of the biggest public health challenges of the 21st century. Affecting more than 500 million people worldwide, obesity costs at least $200 billion each year in the United States alone...
Reducing resistance to chemotherapy in colorectal cancer by inhibition of PHD1
8/20/2015
Scientists at VIB and KU Leuven have shown that blocking the PHD1 oxygen sensor hinders the activation of p53, a transcription factor that aids colorectal cancer (CRC) cells in repairing themselves...
Tool boosts accuracy in assessing breast cancer risk
8/20/2015
UCSF study finds benign conditions triple chance of developing malignancyA national risk model that gauges a woman's chance of developing breast cancer has been refined to give a more accurate...